A larger body doesn’t necessarily mean you have ‘clinical obesity’, according to a proposed new definition of the disease.

An international commission made the case for focusing on body fat quantity and the illnesses people experience.

Can weight loss drugs curb alcohol addictions? This Louisiana doctor is keeping an eye on new findings and emerging research.

These medications have soared in popularity since the FDA first approved Wegovy for weight loss back in 2021. As for what ...

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

For the first time in a decade, U.S. obesity rates have begun to decline, raising hopes that the nation may be turning a ...

Eli Lilly and Novo Nordisk have been competing in the obesity ... for both drugs. Novo Nordisk’s Wegovy made a significant impact on the obesity market when it launched in 2021.

is poised to surpass Novo Nordisk’s Wegovy (semaglutide), despite expectations for continued sales growth for both drugs. Novo Nordisk’s Wegovy made a significant impact on the obesity market when it ...

A key cost-saving provision of the Inflation Reduction Act (IRA) goes into effect in the new year, limiting annual out-of-pocket spending on prescription drugs ... or more in 2021, representing ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20 percent of their body weight, on average, a result that caused the Danish ...

Currently, only 13 states cover GLP-1 drugs for obesity under Medicaid. But a new proposal announced by the Biden administration in November would require Medicare and Medicaid coverage of weight ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish company’s ...